Global state: need for additional medication ‐ medium term · psychosis‐induced aggression or agitation
1 finding from 1 review
Adverse effects/events ‐ extrapyramidal symptoms ‐ medium term Number of instances of extrapyramidal symptoms · psychosis‐induced aggression or agitation
1 finding from 1 review
Satisfaction with treatment: from the perspective of consumer, family and informal carers or professionals/carers at any point during the acute management stage · psychosis‐induced aggression or agitation
1 finding from 1 review
Cost‐effectiveness · psychosis‐induced aggression or agitation
1 finding from 1 review
Adverse effects/events ‐ extrapyramidal symptoms ‐ medium term Number of instances of extrapyramidal symptoms · psychosis‐induced aggression or agitation
It is very uncertain whether benzodiazepines changes adverse effects/events: extrapyramidal symptoms ‐ medium termNumber… compared with placebo (very low certainty).
1 finding from 1 review
Tranquillisation or asleep: sedation ‐ medium termNumber of participants sedated · psychosis‐induced aggression or agitation
It is very uncertain whether benzodiazepines plus antipsychotics changes tranquillisation or asleep: sedation ‐ medium termNumber of… compared with antihistamines plus antipsychotics (very low certainty).
1 finding from 1 review
Global state: no improvement ‐ medium termAs defined in each study · psychosis‐induced aggression or agitation
It is very uncertain whether benzodiazepines plus antipsychotics changes global state: no improvement ‐ medium termAs defined in each study compared with antihistamines plus antipsychotics (very low certainty).
1 finding from 1 review
Global impression ‐ need for additional medication ‐ medium term Number of participants requiring additional medication · psychosis‐induced aggression or agitation
1 finding from 1 review
Adverse effects/events ‐ extrapyramidal symptoms ‐ medium term Number of instances of extrapyramidal symptoms · psychosis‐induced aggression or agitation
It is very uncertain whether benzodiazepines plus antipsychotics changes adverse effects/events: extrapyramidal symptoms ‐ medium termNumber… compared with antihistamines plus antipsychotics (very low certainty).
1 finding from 1 review
Satisfaction with treatment: from the perspective of consumer, family and informal carers or professionals/carers at any point during the acute management stage · psychosis‐induced aggression or agitation
1 finding from 1 review
Cost‐effectiveness · psychosis‐induced aggression or agitation
1 finding from 1 review
Satisfaction with treatment: from the perspective of consumer, family and informal carers or professionals/carers at any point during the acute management stage · psychosis‐induced aggression or agitation
1 finding from 1 review
Economic outcomes: cost‐effectiveness ‐ clinically important · psychosis‐induced aggression or agitation
1 finding from 1 review
Adverse effects: 1. Sedation · psychosis‐induced aggression or agitation
Benzodiazepines showed no clear difference in tranquillisation or asleep: sedation ‐ medium term vs haloperidol… compared with antipsychotics (low certainty).
1 finding from 1 review
Global state: no improvement ‐ vs haloperidol ‐ medium term As defined in each study · psychosis‐induced aggression or agitation
Benzodiazepines showed no clear difference in global state: no improvement ‐ vs haloperidol ‐ medium term As… compared with antipsychotics (low certainty).
1 finding from 1 review
Global state: no improvement ‐ vs olanzapine ‐ medium term As defined in each study · psychosis‐induced aggression or agitation
It is very uncertain whether benzodiazepines changes global state: no improvement ‐ vs olanzapine ‐ medium term As… compared with antipsychotics (very low certainty).
1 finding from 1 review
Intervention not reported
Global state: No clinically important overall improvement (as rated by individual trials) ‐ medium term ( · People with schizophrenia and schizophrenia‐like disorders
The intervention may leads to lower global state: No clinically important overall improvement (as rated… (low certainty).
1 finding from 1 review
Intervention not reported
Mental state: specific ‐ negative symptoms ‐ average endpoint score (SANS, high score = poor) medium term ( · People with schizophrenia and schizophrenia‐like disorders
1 finding from 1 review
Intervention not reported
Mental state: general ‐ average endpoint score (PANSS, high score = poor) ‐ medium term, ( · People with schizophrenia and schizophrenia‐like disorders
1 finding from 1 review
Intervention not reported
Mental state: General ‐ average endpoint score (BPRS, high score = poor) ‐ medium term ( · People with schizophrenia and schizophrenia‐like disorders
1 finding from 1 review